You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 8, 2024

Strides Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has two hundred and forty-six approved drugs.

There are three tentative approvals on STRIDES PHARMA drugs.

Summary for Strides Pharma
US Patents:0
Tradenames:153
Ingredients:149
NDAs:246
Patent Litigation for Strides Pharma: See patent lawsuits for Strides Pharma

Drugs and US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 206813-003 Sep 11, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 070613-001 Feb 2, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 040357-001 May 2, 2000 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 070616-001 Feb 2, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma IBUPROFEN ibuprofen TABLET;ORAL 070986-001 Jul 25, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma ATENOLOL atenolol TABLET;ORAL 073543-001 Dec 19, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma LISINOPRIL lisinopril TABLET;ORAL 076071-003 Jul 1, 2002 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,215,104 ⤷  Try a Trial
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 5,583,152 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-004 Jun 13, 1995 4,258,027 ⤷  Try a Trial
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 4,859,692 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,258,027 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-006 Sep 17, 1986 5,238,924 ⤷  Try a Trial
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 3,524,844 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
➤ Subscribe Tablets 10 mg and 20 mg ➤ Subscribe 2008-02-29
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.